Global Adjuvants Market Insights, Forecast to 2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

An adjuvant is a pharmacological or immunological agent that modifies the effect of other agents.

The global Adjuvants market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Europe and North America are the dominant markets for adjuvants because of the high prevalence of cancer in the two continents.

In terms of production side, this report researches the Adjuvants production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Adjuvants by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Covers:
This report presents an overview of global market for Adjuvants, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Adjuvants, also provides the consumption of main regions and countries.  of the upcoming market potential for Adjuvants, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Adjuvants sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BASF, Syngenta, Bayer CropScience, Novozymes, Koppert Biological Systems, Monsanto, Biobest, Certis USA and Andermatt Biocontrol, etc.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Adjuvants production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Adjuvants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adjuvants sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

 1 Study Coverage
    1.1 Adjuvants Product Introduction
    1.2 Market by Type
        1.2.1 Global Adjuvants Market Size by Type, 2019 VS 2023 VS 2030
        1.2.2 Adjuvant Emulsions
        1.2.3 Pathogen Components
        1.2.4 Particulate Adjuvants
        1.2.5 Combination Adjuvants
    1.3 Market by Application
        1.3.1 Global Adjuvants Market Size by Application, 2019 VS 2023 VS 2030
        1.3.2 Farming
        1.3.3 Veterinary Medicine
        1.3.4 Medicine
        1.3.5 Vaccin
        1.3.6 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Adjuvants Production
    2.1 Global Adjuvants Production Capacity (2019-2030)
    2.2 Global Adjuvants Production by Region: 2019 VS 2023 VS 2030
    2.3 Global Adjuvants Production by Region
        2.3.1 Global Adjuvants Historic Production by Region (2019-2024)
        2.3.2 Global Adjuvants Forecasted Production by Region (2025-2030)
        2.3.3 Global Adjuvants Production Market Share by Region (2019-2030)
    2.4 North America
    2.5 Europe
    2.6 China
    2.7 Japan

 3 Executive Summary
    3.1 Global Adjuvants Revenue Estimates and Forecasts 2019-2030
    3.2 Global Adjuvants Revenue by Region
        3.2.1 Global Adjuvants Revenue by Region: 2019 VS 2023 VS 2030
        3.2.2 Global Adjuvants Revenue by Region (2019-2024)
        3.2.3 Global Adjuvants Revenue by Region (2025-2030)
        3.2.4 Global Adjuvants Revenue Market Share by Region (2019-2030)
    3.3 Global Adjuvants Sales Estimates and Forecasts 2019-2030
    3.4 Global Adjuvants Sales by Region
        3.4.1 Global Adjuvants Sales by Region: 2019 VS 2023 VS 2030
        3.4.2 Global Adjuvants Sales by Region (2019-2024)
        3.4.3 Global Adjuvants Sales by Region (2025-2030)
        3.4.4 Global Adjuvants Sales Market Share by Region (2019-2030)
    3.5 US & Canada
    3.6 Europe
    3.7 China
    3.8 Asia (excluding China)
    3.9 Middle East, Africa and Latin America

 4 Competition by Manufactures
    4.1 Global Adjuvants Sales by Manufacturers
        4.1.1 Global Adjuvants Sales by Manufacturers (2019-2024)
        4.1.2 Global Adjuvants Sales Market Share by Manufacturers (2019-2024)
        4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Adjuvants in 2023
    4.2 Global Adjuvants Revenue by Manufacturers
        4.2.1 Global Adjuvants Revenue by Manufacturers (2019-2024)
        4.2.2 Global Adjuvants Revenue Market Share by Manufacturers (2019-2024)
        4.2.3 Global Top 10 and Top 5 Companies by Adjuvants Revenue in 2023
    4.3 Global Adjuvants Sales Price by Manufacturers
    4.4 Global Key Players of Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.6 Global Key Manufacturers of Adjuvants, Manufacturing Base Distribution and Headquarters
    4.7 Global Key Manufacturers of Adjuvants, Product Offered and Application
    4.8 Global Key Manufacturers of Adjuvants, Date of Enter into This Industry
    4.9 Mergers & Acquisitions, Expansion Plans

 5 Market Size by Type
    5.1 Global Adjuvants Sales by Type
        5.1.1 Global Adjuvants Historical Sales by Type (2019-2024)
        5.1.2 Global Adjuvants Forecasted Sales by Type (2025-2030)
        5.1.3 Global Adjuvants Sales Market Share by Type (2019-2030)
    5.2 Global Adjuvants Revenue by Type
        5.2.1 Global Adjuvants Historical Revenue by Type (2019-2024)
        5.2.2 Global Adjuvants Forecasted Revenue by Type (2025-2030)
        5.2.3 Global Adjuvants Revenue Market Share by Type (2019-2030)
    5.3 Global Adjuvants Price by Type
        5.3.1 Global Adjuvants Price by Type (2019-2024)
        5.3.2 Global Adjuvants Price Forecast by Type (2025-2030)

 6 Market Size by Application
    6.1 Global Adjuvants Sales by Application
        6.1.1 Global Adjuvants Historical Sales by Application (2019-2024)
        6.1.2 Global Adjuvants Forecasted Sales by Application (2025-2030)
        6.1.3 Global Adjuvants Sales Market Share by Application (2019-2030)
    6.2 Global Adjuvants Revenue by Application
        6.2.1 Global Adjuvants Historical Revenue by Application (2019-2024)
        6.2.2 Global Adjuvants Forecasted Revenue by Application (2025-2030)
        6.2.3 Global Adjuvants Revenue Market Share by Application (2019-2030)
    6.3 Global Adjuvants Price by Application
        6.3.1 Global Adjuvants Price by Application (2019-2024)
        6.3.2 Global Adjuvants Price Forecast by Application (2025-2030)

 7 US & Canada
    7.1 US & Canada Adjuvants Market Size by Type
        7.1.1 US & Canada Adjuvants Sales by Type (2019-2030)
        7.1.2 US & Canada Adjuvants Revenue by Type (2019-2030)
    7.2 US & Canada Adjuvants Market Size by Application
        7.2.1 US & Canada Adjuvants Sales by Application (2019-2030)
        7.2.2 US & Canada Adjuvants Revenue by Application (2019-2030)
    7.3 US & Canada Adjuvants Sales by Country
        7.3.1 US & Canada Adjuvants Revenue by Country: 2019 VS 2023 VS 2030
        7.3.2 US & Canada Adjuvants Sales by Country (2019-2030)
        7.3.3 US & Canada Adjuvants Revenue by Country (2019-2030)
        7.3.4 U.S.
        7.3.5 Canada

 8 Europe
    8.1 Europe Adjuvants Market Size by Type
        8.1.1 Europe Adjuvants Sales by Type (2019-2030)
        8.1.2 Europe Adjuvants Revenue by Type (2019-2030)
    8.2 Europe Adjuvants Market Size by Application
        8.2.1 Europe Adjuvants Sales by Application (2019-2030)
        8.2.2 Europe Adjuvants Revenue by Application (2019-2030)
    8.3 Europe Adjuvants Sales by Country
        8.3.1 Europe Adjuvants Revenue by Country: 2019 VS 2023 VS 2030
        8.3.2 Europe Adjuvants Sales by Country (2019-2030)
        8.3.3 Europe Adjuvants Revenue by Country (2019-2030)
        8.3.4 Germany
        8.3.5 France
        8.3.6 U.K.
        8.3.7 Italy
        8.3.8 Russia

 9 China
    9.1 China Adjuvants Market Size by Type
        9.1.1 China Adjuvants Sales by Type (2019-2030)
        9.1.2 China Adjuvants Revenue by Type (2019-2030)
    9.2 China Adjuvants Market Size by Application
        9.2.1 China Adjuvants Sales by Application (2019-2030)
        9.2.2 China Adjuvants Revenue by Application (2019-2030)

 10 Asia (excluding China)
    10.1 Asia Adjuvants Market Size by Type
        10.1.1 Asia Adjuvants Sales by Type (2019-2030)
        10.1.2 Asia Adjuvants Revenue by Type (2019-2030)
    10.2 Asia Adjuvants Market Size by Application
        10.2.1 Asia Adjuvants Sales by Application (2019-2030)
        10.2.2 Asia Adjuvants Revenue by Application (2019-2030)
    10.3 Asia Adjuvants Sales by Region
        10.3.1 Asia Adjuvants Revenue by Region: 2019 VS 2023 VS 2030
        10.3.2 Asia Adjuvants Revenue by Region (2019-2030)
        10.3.3 Asia Adjuvants Sales by Region (2019-2030)
        10.3.4 Japan
        10.3.5 South Korea
        10.3.6 China Taiwan
        10.3.7 Southeast Asia
        10.3.8 India

 11 Middle East, Africa and Latin America
    11.1 Middle East, Africa and Latin America Adjuvants Market Size by Type
        11.1.1 Middle East, Africa and Latin America Adjuvants Sales by Type (2019-2030)
        11.1.2 Middle East, Africa and Latin America Adjuvants Revenue by Type (2019-2030)
    11.2 Middle East, Africa and Latin America Adjuvants Market Size by Application
        11.2.1 Middle East, Africa and Latin America Adjuvants Sales by Application (2019-2030)
        11.2.2 Middle East, Africa and Latin America Adjuvants Revenue by Application (2019-2030)
    11.3 Middle East, Africa and Latin America Adjuvants Sales by Country
        11.3.1 Middle East, Africa and Latin America Adjuvants Revenue by Country: 2019 VS 2023 VS 2030
        11.3.2 Middle East, Africa and Latin America Adjuvants Revenue by Country (2019-2030)
        11.3.3 Middle East, Africa and Latin America Adjuvants Sales by Country (2019-2030)
        11.3.4 Brazil
        11.3.5 Mexico
        11.3.6 Turkey
        11.3.7 Israel
        11.3.8 GCC Countries

 12 Corporate Profiles
    12.1 BASF
        12.1.1 BASF Company Information
        12.1.2 BASF Overview
        12.1.3 BASF Adjuvants Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
        12.1.4 BASF Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 BASF Recent Developments
    12.2 Syngenta
        12.2.1 Syngenta Company Information
        12.2.2 Syngenta Overview
        12.2.3 Syngenta Adjuvants Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
        12.2.4 Syngenta Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 Syngenta Recent Developments
    12.3 Bayer CropScience
        12.3.1 Bayer CropScience Company Information
        12.3.2 Bayer CropScience Overview
        12.3.3 Bayer CropScience Adjuvants Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
        12.3.4 Bayer CropScience Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Bayer CropScience Recent Developments
    12.4 Novozymes
        12.4.1 Novozymes Company Information
        12.4.2 Novozymes Overview
        12.4.3 Novozymes Adjuvants Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
        12.4.4 Novozymes Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Novozymes Recent Developments
    12.5 Koppert Biological Systems
        12.5.1 Koppert Biological Systems Company Information
        12.5.2 Koppert Biological Systems Overview
        12.5.3 Koppert Biological Systems Adjuvants Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
        12.5.4 Koppert Biological Systems Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 Koppert Biological Systems Recent Developments
    12.6 Monsanto
        12.6.1 Monsanto Company Information
        12.6.2 Monsanto Overview
        12.6.3 Monsanto Adjuvants Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
        12.6.4 Monsanto Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.6.5 Monsanto Recent Developments
    12.7 Biobest
        12.7.1 Biobest Company Information
        12.7.2 Biobest Overview
        12.7.3 Biobest Adjuvants Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
        12.7.4 Biobest Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.7.5 Biobest Recent Developments
    12.8 Certis USA
        12.8.1 Certis USA Company Information
        12.8.2 Certis USA Overview
        12.8.3 Certis USA Adjuvants Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
        12.8.4 Certis USA Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.8.5 Certis USA Recent Developments
    12.9 Andermatt Biocontrol
        12.9.1 Andermatt Biocontrol Company Information
        12.9.2 Andermatt Biocontrol Overview
        12.9.3 Andermatt Biocontrol Adjuvants Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
        12.9.4 Andermatt Biocontrol Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
        12.9.5 Andermatt Biocontrol Recent Developments

 13 Industry Chain and Sales Channels Analysis
    13.1 Adjuvants Industry Chain Analysis
    13.2 Adjuvants Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Adjuvants Production Mode & Process
    13.4 Adjuvants Sales and Marketing
        13.4.1 Adjuvants Sales Channels
        13.4.2 Adjuvants Distributors
    13.5 Adjuvants Customers

 14 Adjuvants Market Dynamics
    14.1 Adjuvants Industry Trends
    14.2 Adjuvants Market Drivers
    14.3 Adjuvants Market Challenges
    14.4 Adjuvants Market Restraints

 15 Key Finding in The Global Adjuvants Study

 16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables
    Table 1. Global Adjuvants Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Adjuvant Emulsions
    Table 3. Major Manufacturers of Pathogen Components
    Table 4. Major Manufacturers of Particulate Adjuvants
    Table 5. Major Manufacturers of Combination Adjuvants
    Table 6. Global Adjuvants Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Adjuvants Production by Region: 2019 VS 2023 VS 2030 (K MT)
    Table 8. Global Adjuvants Production by Region (2019-2024) & (K MT)
    Table 9. Global Adjuvants Production by Region (2025-2030) & (K MT)
    Table 10. Global Adjuvants Production Market Share by Region (2019-2024)
    Table 11. Global Adjuvants Production Market Share by Region (2025-2030)
    Table 12. Global Adjuvants Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Adjuvants Revenue by Region (2019-2024) & (US$ Million)
    Table 14. Global Adjuvants Revenue by Region (2025-2030) & (US$ Million)
    Table 15. Global Adjuvants Revenue Market Share by Region (2019-2024)
    Table 16. Global Adjuvants Revenue Market Share by Region (2025-2030)
    Table 17. Global Adjuvants Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 18. Global Adjuvants Sales by Region (2019-2024) & (K MT)
    Table 19. Global Adjuvants Sales by Region (2025-2030) & (K MT)
    Table 20. Global Adjuvants Sales Market Share by Region (2019-2024)
    Table 21. Global Adjuvants Sales Market Share by Region (2025-2030)
    Table 22. Global Adjuvants Sales by Manufacturers (2019-2024) & (K MT)
    Table 23. Global Adjuvants Sales Share by Manufacturers (2019-2024)
    Table 24. Global Adjuvants Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 25. Global Adjuvants Revenue Share by Manufacturers (2019-2024)
    Table 26. Adjuvants Price by Manufacturers 2019-2024 (USD/MT)
    Table 27. Global Key Players of Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
    Table 28. Global Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 29. Global Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvants as of 2023)
    Table 30. Global Key Manufacturers of Adjuvants, Manufacturing Base Distribution and Headquarters
    Table 31. Global Key Manufacturers of Adjuvants, Product Offered and Application
    Table 32. Global Key Manufacturers of Adjuvants, Date of Enter into This Industry
    Table 33. Mergers & Acquisitions, Expansion Plans
    Table 34. Global Adjuvants Sales by Type (2019-2024) & (K MT)
    Table 35. Global Adjuvants Sales by Type (2025-2030) & (K MT)
    Table 36. Global Adjuvants Sales Share by Type (2019-2024)
    Table 37. Global Adjuvants Sales Share by Type (2025-2030)
    Table 38. Global Adjuvants Revenue by Type (2019-2024) & (US$ Million)
    Table 39. Global Adjuvants Revenue by Type (2025-2030) & (US$ Million)
    Table 40. Global Adjuvants Revenue Share by Type (2019-2024)
    Table 41. Global Adjuvants Revenue Share by Type (2025-2030)
    Table 42. Adjuvants Price by Type (2019-2024) & (USD/MT)
    Table 43. Global Adjuvants Price Forecast by Type (2025-2030) & (USD/MT)
    Table 44. Global Adjuvants Sales by Application (2019-2024) & (K MT)
    Table 45. Global Adjuvants Sales by Application (2025-2030) & (K MT)
    Table 46. Global Adjuvants Sales Share by Application (2019-2024)
    Table 47. Global Adjuvants Sales Share by Application (2025-2030)
    Table 48. Global Adjuvants Revenue by Application (2019-2024) & (US$ Million)
    Table 49. Global Adjuvants Revenue by Application (2025-2030) & (US$ Million)
    Table 50. Global Adjuvants Revenue Share by Application (2019-2024)
    Table 51. Global Adjuvants Revenue Share by Application (2025-2030)
    Table 52. Adjuvants Price by Application (2019-2024) & (USD/MT)
    Table 53. Global Adjuvants Price Forecast by Application (2025-2030) & (USD/MT)
    Table 54. US & Canada Adjuvants Sales by Type (2019-2024) & (K MT)
    Table 55. US & Canada Adjuvants Sales by Type (2025-2030) & (K MT)
    Table 56. US & Canada Adjuvants Revenue by Type (2019-2024) & (US$ Million)
    Table 57. US & Canada Adjuvants Revenue by Type (2025-2030) & (US$ Million)
    Table 58. US & Canada Adjuvants Sales by Application (2019-2024) & (K MT)
    Table 59. US & Canada Adjuvants Sales by Application (2025-2030) & (K MT)
    Table 60. US & Canada Adjuvants Revenue by Application (2019-2024) & (US$ Million)
    Table 61. US & Canada Adjuvants Revenue by Application (2025-2030) & (US$ Million)
    Table 62. US & Canada Adjuvants Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 63. US & Canada Adjuvants Revenue by Country (2019-2024) & (US$ Million)
    Table 64. US & Canada Adjuvants Revenue by Country (2025-2030) & (US$ Million)
    Table 65. US & Canada Adjuvants Sales by Country (2019-2024) & (K MT)
    Table 66. US & Canada Adjuvants Sales by Country (2025-2030) & (K MT)
    Table 67. Europe Adjuvants Sales by Type (2019-2024) & (K MT)
    Table 68. Europe Adjuvants Sales by Type (2025-2030) & (K MT)
    Table 69. Europe Adjuvants Revenue by Type (2019-2024) & (US$ Million)
    Table 70. Europe Adjuvants Revenue by Type (2025-2030) & (US$ Million)
    Table 71. Europe Adjuvants Sales by Application (2019-2024) & (K MT)
    Table 72. Europe Adjuvants Sales by Application (2025-2030) & (K MT)
    Table 73. Europe Adjuvants Revenue by Application (2019-2024) & (US$ Million)
    Table 74. Europe Adjuvants Revenue by Application (2025-2030) & (US$ Million)
    Table 75. Europe Adjuvants Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 76. Europe Adjuvants Revenue by Country (2019-2024) & (US$ Million)
    Table 77. Europe Adjuvants Revenue by Country (2025-2030) & (US$ Million)
    Table 78. Europe Adjuvants Sales by Country (2019-2024) & (K MT)
    Table 79. Europe Adjuvants Sales by Country (2025-2030) & (K MT)
    Table 80. China Adjuvants Sales by Type (2019-2024) & (K MT)
    Table 81. China Adjuvants Sales by Type (2025-2030) & (K MT)
    Table 82. China Adjuvants Revenue by Type (2019-2024) & (US$ Million)
    Table 83. China Adjuvants Revenue by Type (2025-2030) & (US$ Million)
    Table 84. China Adjuvants Sales by Application (2019-2024) & (K MT)
    Table 85. China Adjuvants Sales by Application (2025-2030) & (K MT)
    Table 86. China Adjuvants Revenue by Application (2019-2024) & (US$ Million)
    Table 87. China Adjuvants Revenue by Application (2025-2030) & (US$ Million)
    Table 88. Asia Adjuvants Sales by Type (2019-2024) & (K MT)
    Table 89. Asia Adjuvants Sales by Type (2025-2030) & (K MT)
    Table 90. Asia Adjuvants Revenue by Type (2019-2024) & (US$ Million)
    Table 91. Asia Adjuvants Revenue by Type (2025-2030) & (US$ Million)
    Table 92. Asia Adjuvants Sales by Application (2019-2024) & (K MT)
    Table 93. Asia Adjuvants Sales by Application (2025-2030) & (K MT)
    Table 94. Asia Adjuvants Revenue by Application (2019-2024) & (US$ Million)
    Table 95. Asia Adjuvants Revenue by Application (2025-2030) & (US$ Million)
    Table 96. Asia Adjuvants Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 97. Asia Adjuvants Revenue by Region (2019-2024) & (US$ Million)
    Table 98. Asia Adjuvants Revenue by Region (2025-2030) & (US$ Million)
    Table 99. Asia Adjuvants Sales by Region (2019-2024) & (K MT)
    Table 100. Asia Adjuvants Sales by Region (2025-2030) & (K MT)
    Table 101. Middle East, Africa and Latin America Adjuvants Sales by Type (2019-2024) & (K MT)
    Table 102. Middle East, Africa and Latin America Adjuvants Sales by Type (2025-2030) & (K MT)
    Table 103. Middle East, Africa and Latin America Adjuvants Revenue by Type (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Adjuvants Revenue by Type (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Adjuvants Sales by Application (2019-2024) & (K MT)
    Table 106. Middle East, Africa and Latin America Adjuvants Sales by Application (2025-2030) & (K MT)
    Table 107. Middle East, Africa and Latin America Adjuvants Revenue by Application (2019-2024) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Adjuvants Revenue by Application (2025-2030) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Adjuvants Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 110. Middle East, Africa and Latin America Adjuvants Revenue by Country (2019-2024) & (US$ Million)
    Table 111. Middle East, Africa and Latin America Adjuvants Revenue by Country (2025-2030) & (US$ Million)
    Table 112. Middle East, Africa and Latin America Adjuvants Sales by Country (2019-2024) & (K MT)
    Table 113. Middle East, Africa and Latin America Adjuvants Sales by Country (2025-2030) & (K MT)
    Table 114. BASF Company Information
    Table 115. BASF Description and Major Businesses
    Table 116. BASF Adjuvants Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 117. BASF Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. BASF Recent Development
    Table 119. Syngenta Company Information
    Table 120. Syngenta Description and Major Businesses
    Table 121. Syngenta Adjuvants Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 122. Syngenta Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Syngenta Recent Development
    Table 124. Bayer CropScience Company Information
    Table 125. Bayer CropScience Description and Major Businesses
    Table 126. Bayer CropScience Adjuvants Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 127. Bayer CropScience Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Bayer CropScience Recent Development
    Table 129. Novozymes Company Information
    Table 130. Novozymes Description and Major Businesses
    Table 131. Novozymes Adjuvants Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 132. Novozymes Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Novozymes Recent Development
    Table 134. Koppert Biological Systems Company Information
    Table 135. Koppert Biological Systems Description and Major Businesses
    Table 136. Koppert Biological Systems Adjuvants Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 137. Koppert Biological Systems Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Koppert Biological Systems Recent Development
    Table 139. Monsanto Company Information
    Table 140. Monsanto Description and Major Businesses
    Table 141. Monsanto Adjuvants Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 142. Monsanto Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Monsanto Recent Development
    Table 144. Biobest Company Information
    Table 145. Biobest Description and Major Businesses
    Table 146. Biobest Adjuvants Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 147. Biobest Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Biobest Recent Development
    Table 149. Certis USA Company Information
    Table 150. Certis USA Description and Major Businesses
    Table 151. Certis USA Adjuvants Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 152. Certis USA Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Certis USA Recent Development
    Table 154. Andermatt Biocontrol Company Information
    Table 155. Andermatt Biocontrol Description and Major Businesses
    Table 156. Andermatt Biocontrol Adjuvants Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 157. Andermatt Biocontrol Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Andermatt Biocontrol Recent Development
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. Adjuvants Distributors List
    Table 162. Adjuvants Customers List
    Table 163. Adjuvants Market Trends
    Table 164. Adjuvants Market Drivers
    Table 165. Adjuvants Market Challenges
    Table 166. Adjuvants Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Adjuvants Product Picture
    Figure 2. Global Adjuvants Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Adjuvants Market Share by Type in 2023 & 2030
    Figure 4. Adjuvant Emulsions Product Picture
    Figure 5. Pathogen Components Product Picture
    Figure 6. Particulate Adjuvants Product Picture
    Figure 7. Combination Adjuvants Product Picture
    Figure 8. Global Adjuvants Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Adjuvants Market Share by Application in 2023 & 2030
    Figure 10. Farming
    Figure 11. Veterinary Medicine
    Figure 12. Medicine
    Figure 13. Vaccin
    Figure 14. Others
    Figure 15. Adjuvants Report Years Considered
    Figure 16. Global Adjuvants Capacity, Production and Utilization (2019-2030) & (K MT)
    Figure 17. Global Adjuvants Production Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global Adjuvants Production Market Share by Region (2019-2030)
    Figure 19. Adjuvants Production Growth Rate in North America (2019-2030) & (K MT)
    Figure 20. Adjuvants Production Growth Rate in Europe (2019-2030) & (K MT)
    Figure 21. Adjuvants Production Growth Rate in China (2019-2030) & (K MT)
    Figure 22. Adjuvants Production Growth Rate in Japan (2019-2030) & (K MT)
    Figure 23. Global Adjuvants Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 24. Global Adjuvants Revenue 2019-2030 (US$ Million)
    Figure 25. Global Adjuvants Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Figure 26. Global Adjuvants Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 27. Global Adjuvants Revenue Market Share by Region (2019-2030)
    Figure 28. Global Adjuvants Sales 2019-2030 ((K MT)
    Figure 29. Global Adjuvants Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K MT)
    Figure 30. Global Adjuvants Sales Market Share by Region (2019-2030)
    Figure 31. US & Canada Adjuvants Sales YoY (2019-2030) & (K MT)
    Figure 32. US & Canada Adjuvants Revenue YoY (2019-2030) & (US$ Million)
    Figure 33. Europe Adjuvants Sales YoY (2019-2030) & (K MT)
    Figure 34. Europe Adjuvants Revenue YoY (2019-2030) & (US$ Million)
    Figure 35. China Adjuvants Sales YoY (2019-2030) & (K MT)
    Figure 36. China Adjuvants Revenue YoY (2019-2030) & (US$ Million)
    Figure 37. Asia (excluding China) Adjuvants Sales YoY (2019-2030) & (K MT)
    Figure 38. Asia (excluding China) Adjuvants Revenue YoY (2019-2030) & (US$ Million)
    Figure 39. Middle East, Africa and Latin America Adjuvants Sales YoY (2019-2030) & (K MT)
    Figure 40. Middle East, Africa and Latin America Adjuvants Revenue YoY (2019-2030) & (US$ Million)
    Figure 41. The Adjuvants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 42. The Top 5 and 10 Largest Manufacturers of Adjuvants in the World: Market Share by Adjuvants Revenue in 2023
    Figure 43. Global Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 44. Global Adjuvants Sales Market Share by Type (2019-2030)
    Figure 45. Global Adjuvants Revenue Market Share by Type (2019-2030)
    Figure 46. Global Adjuvants Sales Market Share by Application (2019-2030)
    Figure 47. Global Adjuvants Revenue Market Share by Application (2019-2030)
    Figure 48. US & Canada Adjuvants Sales Market Share by Type (2019-2030)
    Figure 49. US & Canada Adjuvants Revenue Market Share by Type (2019-2030)
    Figure 50. US & Canada Adjuvants Sales Market Share by Application (2019-2030)
    Figure 51. US & Canada Adjuvants Revenue Market Share by Application (2019-2030)
    Figure 52. US & Canada Adjuvants Revenue Share by Country (2019-2030)
    Figure 53. US & Canada Adjuvants Sales Share by Country (2019-2030)
    Figure 54. U.S. Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 55. Canada Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 56. Europe Adjuvants Sales Market Share by Type (2019-2030)
    Figure 57. Europe Adjuvants Revenue Market Share by Type (2019-2030)
    Figure 58. Europe Adjuvants Sales Market Share by Application (2019-2030)
    Figure 59. Europe Adjuvants Revenue Market Share by Application (2019-2030)
    Figure 60. Europe Adjuvants Revenue Share by Country (2019-2030)
    Figure 61. Europe Adjuvants Sales Share by Country (2019-2030)
    Figure 62. Germany Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 63. France Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 64. U.K. Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 65. Italy Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 66. Russia Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 67. China Adjuvants Sales Market Share by Type (2019-2030)
    Figure 68. China Adjuvants Revenue Market Share by Type (2019-2030)
    Figure 69. China Adjuvants Sales Market Share by Application (2019-2030)
    Figure 70. China Adjuvants Revenue Market Share by Application (2019-2030)
    Figure 71. Asia Adjuvants Sales Market Share by Type (2019-2030)
    Figure 72. Asia Adjuvants Revenue Market Share by Type (2019-2030)
    Figure 73. Asia Adjuvants Sales Market Share by Application (2019-2030)
    Figure 74. Asia Adjuvants Revenue Market Share by Application (2019-2030)
    Figure 75. Asia Adjuvants Revenue Share by Region (2019-2030)
    Figure 76. Asia Adjuvants Sales Share by Region (2019-2030)
    Figure 77. Japan Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 78. South Korea Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 79. China Taiwan Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 80. Southeast Asia Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 81. India Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 82. Middle East, Africa and Latin America Adjuvants Sales Market Share by Type (2019-2030)
    Figure 83. Middle East, Africa and Latin America Adjuvants Revenue Market Share by Type (2019-2030)
    Figure 84. Middle East, Africa and Latin America Adjuvants Sales Market Share by Application (2019-2030)
    Figure 85. Middle East, Africa and Latin America Adjuvants Revenue Market Share by Application (2019-2030)
    Figure 86. Middle East, Africa and Latin America Adjuvants Revenue Share by Country (2019-2030)
    Figure 87. Middle East, Africa and Latin America Adjuvants Sales Share by Country (2019-2030)
    Figure 88. Brazil Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 89. Mexico Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 90. Turkey Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 91. Israel Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 92. GCC Countries Adjuvants Revenue (2019-2030) & (US$ Million)
    Figure 93. Adjuvants Value Chain
    Figure 94. Adjuvants Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed

An adjuvant is a pharmacological or immunological agent that modifies the effect of other agents.

The global Adjuvants market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Europe and North America are the dominant markets for adjuvants because of the high prevalence of cancer in the two continents.

In terms of production side, this report researches the Adjuvants production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Adjuvants by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Covers:
This report presents an overview of global market for Adjuvants, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Adjuvants, also provides the consumption of main regions and countries.  of the upcoming market potential for Adjuvants, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Adjuvants sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BASF, Syngenta, Bayer CropScience, Novozymes, Koppert Biological Systems, Monsanto, Biobest, Certis USA and Andermatt Biocontrol, etc.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Adjuvants production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Adjuvants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adjuvants sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.